ZYDUS PHARMACEUTICALS USA, INC.
Showing salary data for 4 positions at ZYDUS PHARMACEUTICALS USA, INC.
Comprehensive H-1B visa salary information for ZYDUS PHARMACEUTICALS USA, INC. in the USA. Explore specialty occupation wages, job titles, and location-specific compensation at this employer. Compare with industry standards and other H-1B sponsors.
Employer Stats
Total Positions
4
Average Salary
$114,306.25
| Job Title | Employer | Location | Salary | Date ↓ |
|---|---|---|---|---|
| Senior Analyst, Medicaid & Government Pricing | ZYDUS PHARMACEUTICALS USA, INC. | Pennington, NJ | $87,651 | 2024-10-01 |
| Manager, Accounts Payable | ZYDUS PHARMACEUTICALS USA, INC. | PENNINGTON, NJ | $99,861 | 2024-09-17 |
| Supply Chain Analyst | ZYDUS PHARMACEUTICALS USA, INC. | Pennington, NJ | $70,075 | 2023-10-01 |
| Director - IT | ZYDUS PHARMACEUTICALS USA, INC. | Pennington, NJ | $199,638 | 2023-08-31 |
About ZYDUS PHARMACEUTICALS USA, INC. H-1B Visa Data
This page provides detailed H-1B visa salary information for positions at ZYDUS PHARMACEUTICALS USA, INC.. The data presented here comes from Labor Condition Applications (LCAs) filed with the U.S. Department of Labor. With 4 positions recorded, this information offers valuable insight into ZYDUS PHARMACEUTICALS USA, INC.'s compensation practices for specialty occupation workers.
Understanding Salary Data
The prevailing wage shown represents the minimum wage employers must pay H-1B workers based on the job's skill level and location. The average salary of $114,306reflects the typical compensation package at ZYDUS PHARMACEUTICALS USA, INC. for H-1B specialty occupation roles.
Using This Information
When evaluating potential employment at ZYDUS PHARMACEUTICALS USA, INC., consider how these salary figures compare to industry standards and regional cost of living. The detailed position information can help you understand the company's hiring priorities and how your skills align with their needs. Use the filters above to refine your search by job title, location, or salary range.